Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2025 Earnings Call Transcript
Operator: Good afternoon and welcome to the Sangamo Therapeutics First Quarter 2025 Teleconference Call. Please be advised that today's conference is being recorded.
Sangamo Therapeutics Inc (SGMO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 53,600 | $35,151 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.69 | 6,784 | Director | 32,484 | 2022-06-03 | Filing | |
| $3.60 | 5,000 | Director | 48,700 | 2022-06-01 | Filing | |
| $5.20 | 3,000 | Director | 13,000 | 2020-03-18 | Filing | |
| $4.99 | 5,000 | Director | 30,000 | 2020-03-17 | Filing | |
| $5.67 | 5,000 | Director | 25,000 | 2020-03-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.50 | 6,000,000 | Large Shareholder | 17,652,466 | 2023-09-26 | Filing | |
| $5.27 | 100,000 | Large Shareholder | 23,652,466 | 2022-08-30 | Filing | |
| $5.33 | 400,000 | Large Shareholder | 23,752,466 | 2022-08-29 | Filing | |
| $8.51 | 2,764 | Large Shareholder | 24,152,466 | 2021-12-28 | Filing | |
| $8.56 | 600 | Large Shareholder | 24,155,230 | 2021-12-27 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,374,728 | $6,149,822 | 0% | |
| 2. | 5,445,018 | $3,570,843 | 0% | |
| 3. | 1,097,834 | $719,960 | 0% | |
| 4. | 955,239 | $626,446 | 0% | |
| 5. | 562,936 | $369,173 | 0% |
News See All
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q4 2024 Earnings Call Transcript
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q4 2024 Earnings Call Transcript March 17, 2025Sangamo Therapeutics, Inc. misses on earnings expectations.
15 Small-Cap Stocks Poised to Outperform in 2025
Fifteen small-cap stocks—predominantly under the technology sector—are taking center stage this year, boasting triple- to quadruple-digit performance in their share prices, thanks to the booming Artificial...
Top 11 CRISPR Stocks to Invest In
The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, and leveraging cutting-edge technologies like pharmacogenomics, digital...
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to the Sangamo Therapeutics Third Quarter 2024 Teleconference Call. Please be advised that today's conference is being recorded.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Sangamo Therapeutics Second Quarter 2024 Teleconference Call. Please be advised that today's conference is being recorded.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Sangamo Therapeutics First Quarter 2024 Teleconference Call. At this time, all participants are in a listen-only mode.
5 Hot Penny Stock On the Move
Applied Therapeutics Inc (NASDAQ:APLT) shares jumped about 79% over the past five days through February 22.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2023 Earnings Call Transcript
Operator: Good morning, and thank you for standing by. Welcome to the Sangamo Third Quarter 2023 Teleconference Call. At this time, all participants are in a listen-only mode.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Sangamo Second Quarter 2023 Teleconference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
